From: The outcome of genetic and non-genetic pediatric cardiomyopathies
Alive | Died | Total | P-value | Odds ratio | Relative Risk | ||
---|---|---|---|---|---|---|---|
Gender | Male | 56 | 24 | 80 | 0.568 | 1 | 1 |
Female | 56 | 24 | 80 | ||||
Mode of presentation | Heart failure | 81 | 37 | 118 | 0.038 | ||
Cardiogenic shock | 18 | 11 | 29 | ||||
Asymptomatic | 13 | 0 | 13 | ||||
Primary or secondary | Primary | 57 | 19 | 76 | 0.127 | 0.63 | 0.72 |
Secondary | 55 | 29 | 84 | ||||
Syndromic | Yes | 9 | 5 | 14 | 0.415 | 1.33 | 1.21 |
No | 103 | 43 | 146 | ||||
Primary or secondary | Primary | 53 | 19 | 4 | 0.483 | 0.62 | 0.72 |
Secondary | 50 | 29 | 5 | ||||
Suspected viral illness | Yes | 22 | 2 | 24 | 0.008 | 0.18 | 0.25 |
No | 90 | 46 | 136 | ||||
LV noncompaction | Yes | 84 | 46 | 130 | 0.001 | 7.67 | 5.31 |
No | 28 | 2 | 30 | ||||
Consanguineous parents | Yes | 32 | 26 | 58 | 0.002 | 2.95 | 2.08 |
No | 80 | 22 | 102 | ||||
F/H of CMP | Yes | 9 | 12 | 21 | 0.005 | 3.81 | 2.21 |
No | 103 | 36 | 139 | ||||
Genetic study | Positive/Abnormal | 17 | 3 | 20 | 0.012 | ||
Negative/Normal | 35 | 6 | 41 | ||||
Pending | 9 | 21 | 30 | ||||
Normal | 51 | 18 | 69 | ||||
Age of presentation | 6 months or Less | 40 | 22 | 62 | 0.152 | 1.52 | 1.34 |
More than 6 months | 72 | 26 | 98 | ||||
Ejection fraction at presentation | 20% or Less | 10 | 25 | 35 | < 0.001 | 11.09 | 3.88 |
More than 20% | 102 | 23 | 125 | ||||
Admission on first presentation | Yes | 78 | 44 | 122 | 0.002 | 4.79 | 3.43 |
No | 34 | 4 | 38 | ||||
ICU admission | Yes | 51 | 29 | 5 | 0.045 | 2.27 | 1.81 |
No | 40 | 10 | 0 | ||||
IVIg administration | Yes | 35 | 9 | 44 | 0.074 | 0.51 | 0.61 |
No | 77 | 39 | 116 | ||||
ICU admission | Yes | 57 | 32 | 89 | 0.047 | 1.93 | 1.6 |
No | 55 | 16 | 71 | ||||
Ventilation | Yes | 74 | 21 | 95 | 0.007 | 0.4 | 0.53 |
No | 38 | 27 | 65 | ||||
Inotropes | Yes | 70 | 21 | 91 | 0.022 | 0.47 | 0.59 |
No | 42 | 27 | 69 | ||||
Carvidolol | Yes | 10 | 8 | 18 | 0.127 | 2.04 | 1.58 |
No | 102 | 40 | 142 | ||||
Digoxin | Yes | 39 | 16 | 55 | 0.503 | 1.22 | 1.14 |
No | 73 | 32 | 105 |